The Weekly Roundup: May 19-23

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Weighing In on Biologics and JAK Inhibitors for Atopic Dermatitis

Christopher Bunick, MD, PhD, discusses key differences in AD biologics and challenges in achieving optimal treatment targets.

TNF-Alpha Linked to CSU Severity

Research reveals a significant link between TNF-alpha serum levels and the severity of chronic spontaneous urticaria, suggesting new therapeutic avenues for treatment.

Julia Zimmermann PD, PhD, Demonstrates PHLAS, A New Cold Plasma Skin Care Device

Discover how Julia Zimmermann, PD, PhD's PHLAS innovates cold plasma technology for skin care, enhancing treatments for acne and skin health.

No Link Found Between JAK Inhibitor Use and Unprovoked Venous Thromboembolisms in Adults with Atopic Dermatitis

The study offers reassurance regarding the safety profile of JAKis in patients with severe atopic dermatitis, particularly concerning their impact on venous thromboembolic events.

Psoriasis Linked to Sleep Disorders in Diverse Adults

Psoriasis significantly impacts sleep health, with diverse populations facing increased risks of sleep disorders, highlighting urgent clinical needs for tailored interventions.

Triple-Combination Acne Gel Demonstrates Long-Term Safety and Efficacy

A new study highlights the significant long-term improvements in lesions and scarring of a clindamycin phosphate 1.2%, adapalene 0.15%, and benzoyl peroxide 3.1% formulation.

Expert Insights Highlight Novel ITK Inhibition WithSoquelitinib for AD

Albert Chiou, MD, MBA, discusses early clinical data on soquelitinib for atopic dermatitis, highlighting its targeted ITK inhibition, dose-dependent efficacy, favorable safety profile, and more.

Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor

A melanoma survivor shares her journey, emphasizing the importance of sun safety and regular skin exams to prevent skin cancer.

Revolutionizing Acne Treatments and Skin Care with Cold Plasma Technology

Julia Zimmermann, PD, PHD's innovative cold plasma technology for acne treatment, developed through extensive research, promises effective results for clearer skin.

New Study Evaluates Accuracy of Hand Eczema Self-Assessments

Explore the evolving landscape of self-reported hand eczema severity assessments, highlighting their potential and challenges in clinical research and digital health.

Space Science is Revolutionizing Cancer Research

New research explores how microgravity and cosmic radiation influence cancer cell behavior, immune responses, and potential advancements in oncology treatments.

Shaant ClearSkin Probiotic Granted Patent for Acne Relief

Discover how Shaant ClearSkin Probiotic offers a holistic approach to acne treatment by targeting gut health and hormonal balance for clearer skin.

The Impact of Alcohol-Based Hand Sanitizers on Skin Barrier Function

Four variations of virucidal sanitizers were evaluated for their effect on skin irritation, erythema, transepidermal water loss, and more.

Journal Digest: May 21

This review of the latest dermatologic studies includes insights into chronic hand eczema, including self-reported severity, burden of pain and use of analgesics, and more.

AI Shows Promise in Early Medical Education

Explore how AI, particularly ChatGPT, impacts dermatology education, revealing strengths and limitations in clinical decision-making and training.

Azathioprine: A Potential Long-Term Treatment for Alopecia Areata

A 10-year study reveals azathioprine's impressive 93% hair regrowth rate in patients with moderate to severe alopecia, highlighting its long-term efficacy and safety.

AC-201 Shows Strong Phase 2 Results in Psoriasis Trial

Accropeutics reveals promising Phase 2 trial results for AC-201, a selective TYK2/JAK1 inhibitor, showing significant efficacy in treating plaque psoriasis.

Triveni Bio Launches First-in-Human Trial for TRIV-509 in Atopic Dermatitis

Triveni Bio initiates a phase 1 trial for TRIV-509, a promising treatment for atopic dermatitis, targeting key inflammatory pathways.

Combining Topical Products with Anti-Aging Procedure Synergistically Improves the Skin Barrier

A recent study reveals that combining topical anti-aging products with Thermage enhances skin hydration and reduces fine lines for lasting results.

Tralokinumab Eases Joint Pain in Patients with AD

Tralokinumab offers a promising alternative for patients with atopic dermatitis experiencing dupilumab-related arthralgia, achieving skin clearance and symptom relief.

Cutibacterium acnes Dominates the Post-Laser Skin Microbiome

Researchers reveal the resilience of Cutibacterium acnes in the skin microbiome post-laser treatments, suggesting its beneficial roles in skin health and aging.

Ascletis Receives FDA Clearance to Advance ASC50, a Novel Oral IL-17 Inhibitor, Into Phase 1 Psoriasis Trial

Ascletis Pharma's investigational new drug application for ASC50 gains FDA clearanc for a phase 1 trial for mild to moderate psoriasis.

Real-World Data on the Adverse Effects of Apremilast and Deucravacitinib for Psoriasis

A recent analysis reveals safety profiles of apremilast and deucravacitinib for psoriasis, highlighting unique adverse events and long-term monitoring needs.

Quoin Receives FDA Clearance for Second Netherton Trial

Quoin Pharmaceuticals advances QRX003 for Netherton Syndrome, receiving FDA clearance for a pivotal trial to assess its effectiveness and safety.

FDA Approves Arcutis’ Roflumilast Foam for Plaque Psoriasis

FDA approves Arcutis' roflumilast foam, a groundbreaking treatment for plaque psoriasis, offering a steroid-free, effective solution for patients aged 12 and older.

Suicide Risk Management Crucial in Dermatological Care

Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.

Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness

A melanoma survivor shares her journey, emphasizing the importance of early detection and regular skin exams for skin cancer awareness.

Evolving Melanoma Outcomes and Care: Insights from Victor Gall, MD

As melanoma rates rise, Victor Gall, MD, emphasizes proactive care, early detection, and innovative treatments to improve patient outcomes and survival rates.

ICYMI: FDA Grants Adalimumab-aaty Interchangeability Designation; Celltrion Lowers WAC List Price

Celltrion's Yuflyma gains full FDA interchangeability, enhancing patient access and affordability for various inflammatory conditions.

Study Supports Dual Approach for Treatment-Resistant Vitiligo

Discover the promising efficacy and safety of combining platelet-rich plasma with fractional laser therapy for treating vitiligo in adults.

Understanding and Managing Dermatologic Manifestations of Diabetes

Skin care for diabetes management focuses on prevention, routine inspections, and maintaining healthy skin to avoid complications.